Statins and the Older Population: When Is It Beneficial and When Is It Not? - Frankly Speaking EP 96

Summary: Evidence of the efficacy of statins to reduce ASCVD morbidity and mortality in individuals > 75 years who have known clinical ASCVD (secondary prevention) is well established. Primary prevention in this population has not been as clear. Join us while we discuss a recent study in the BMJ which assessed the benefits of statins for primary prevention of ASCVD morbidity and mortality in individuals > 75 years with and without DM. Guest: Susan Feeney, DNP, FNP-BC